Terms: = Germ cell tumor AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
1256 results:
1. KIAA0040 enhances glioma growth by controlling the JAK2/stat3 signalling pathway.
He J; Xue K; Fan F; Li L; Rao X; Liu W; Nie C
J Cell Mol Med; 2024 Apr; 28(8):e18332. PubMed ID: 38661644
[TBL] [Abstract] [Full Text] [Related]
2. Expression of stat3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
3. Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through stat3/Akt signaling pathway.
Yao N; Ma Q; Yi W; Zhu Y; Liu Y; Gao X; Zhang Q; Luo W
J Cancer Res Clin Oncol; 2024 Apr; 150(4):202. PubMed ID: 38630320
[TBL] [Abstract] [Full Text] [Related]
4. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/stat3 axis.
Qiu Y; Pei D; Wang M; Wang Q; Duan W; Wang L; Liu K; Guo Y; Luo L; Guo Z; Guan F; Wang Z; Xing A; Liu Z; Ma Z; Jiang G; Yan D; Liu X; Zhang Z; Wang W
CNS Neurosci Ther; 2024 Apr; 30(4):e14709. PubMed ID: 38605477
[TBL] [Abstract] [Full Text] [Related]
5. tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas.
Tuysuz EC; Mourati E; Rosberg R; Moskal A; Gialeli C; Johansson E; Governa V; Belting M; Pietras A; Blom AM
J Exp Clin Cancer Res; 2024 Apr; 43(1):98. PubMed ID: 38561856
[TBL] [Abstract] [Full Text] [Related]
6. YTHDF1 promotes the viability and self‑renewal of glioma stem cells by enhancing LINC00900 stability.
Zhang Y; Zhu Y; Zhang Y; Liu Z; Zhao X
Int J Oncol; 2024 May; 64(5):. PubMed ID: 38551160
[TBL] [Abstract] [Full Text] [Related]
7. Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/stat3 pathway.
Zhang C; Peng Q; Tang Y; Wang C; Wang S; Yu D; Hou S; Wang Y; Zhang L; Lin N
J Cancer Res Clin Oncol; 2024 Mar; 150(3):168. PubMed ID: 38546908
[TBL] [Abstract] [Full Text] [Related]
8. Potential diagnostic and drug target markers in glioblastoma.
Ahsan H; Asghar M; Malik SI
Sci Rep; 2024 Mar; 14(1):7292. PubMed ID: 38538691
[TBL] [Abstract] [Full Text] [Related]
9. Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.
Jin X; Zhu J; Yu H; Shi S; Shen K; Gu J; Yin Z; Yu Z; Wu J
PLoS One; 2024; 19(3):e0298055. PubMed ID: 38530810
[TBL] [Abstract] [Full Text] [Related]
10. EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma.
Yang E; Hong B; Wang Y; Wang Q; Zhao J; Cui X; Wu Y; Yang S; Su D; Liu X; Kang C
Cancer Lett; 2024 Apr; 588():216812. PubMed ID: 38490327
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem cells by Blocking the stat3 Signaling Pathway.
Yuk N; Jung HJ
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197
[TBL] [Abstract] [Full Text] [Related]
12. Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations.
Zhang ZG; Zhu HM; Hua HK
Skin Res Technol; 2024 Mar; 30(3):e13618. PubMed ID: 38468436
[TBL] [Abstract] [Full Text] [Related]
13. Zeaxanthin impairs angiogenesis and tumor growth of glioblastoma: An in vitro and in vivo study.
Lu F; Wu Q; Lei J; Zhou Y; Liu Y; Zhu N; Yu Y; Lin L; Hu M
Arch Biochem Biophys; 2024 Apr; 754():109957. PubMed ID: 38467357
[TBL] [Abstract] [Full Text] [Related]
14. Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression.
Khan F; Lin Y; Ali H; Pang L; Dunterman M; Hsu WH; Frenis K; Grant Rowe R; Wainwright DA; McCortney K; Billingham LK; Miska J; Horbinski C; Lesniak MS; Chen P
Nat Commun; 2024 Mar; 15(1):1987. PubMed ID: 38443336
[TBL] [Abstract] [Full Text] [Related]
15. Antiproliferative effect of Potentilla fulgens on glioblastoma cancer cells through downregulation of Akt/mTOR signaling pathway.
Kandemir SI; Ipek P
J Cancer Res Ther; 2023 Oct; 19(7):1818-1824. PubMed ID: 38376284
[TBL] [Abstract] [Full Text] [Related]
16. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
[TBL] [Abstract] [Full Text] [Related]
17. Exposure of human glioblastoma cells to thimerosal inhibits the thioredoxin system and decreases tumor growth-related factors.
Bramatti I; Aschner M; Branco V; Carvalho C
Toxicol Appl Pharmacol; 2024 Mar; 484():116844. PubMed ID: 38325586
[TBL] [Abstract] [Full Text] [Related]
18. Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1β and IL-6 signaling pathways in spinocerebellar ataxia type 3.
Chen IC; Chen WL; Chang KH; Lee JW; Lin TH; Lin W; Chen CM; Lee-Chen GJ
Eur J Pharmacol; 2024 Mar; 967():176370. PubMed ID: 38320719
[TBL] [Abstract] [Full Text] [Related]
19. DNA methylation-mediated repression of microRNA-410 promotes the growth of human glioma cells and triggers cell apoptosis through its interaction with stat3.
Wenfu Z; Bin L; Binchan R; Jingling L; Zhenchang W; Zhengdi W; Lei Y
Sci Rep; 2024 Jan; 14(1):1556. PubMed ID: 38238515
[TBL] [Abstract] [Full Text] [Related]
20. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
[TBL] [Abstract] [Full Text] [Related]
[Next]
